ACHV — Achieve Life Sciences Inc
Achieve Life Sciences Inc (ACHV) is listed on NASDAQ.
Its activity is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.
Searching for the Achieve Life Sciences Inc share price, or whether to buy ACHV? This page brings together a live chart, momentum and risk scores, fresh news and community sentiment.
VAQO runs a statistical model over ACHV that reads seven technical indicators and translates them into an opportunity score and a risk score — including which factors drove them.
What ACHV is
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and markets cytisinicline for smoking and nicotine addiction cessation in the United States and internationally. The company is headquartered in Vancouver, Canada.…
Achieve Life Sciences Inc is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.
It trades on NASDAQ as a common stock.
ACHV size and valuation
At roughly $724.8M, ACHV is a small-cap.
Earnings per share are negative at -1.69, so there is no meaningful price-to-earnings multiple to quote.
Beta is 2.31: historically it has moved more than the market.
ACHV over the past year
Over the past year ACHV has traded between $2.62 and $8.64, and the current price sits at 68% of that range.
The 50-day average is $7.47 against a 200-day average of $5.47 — the shorter average sits above the longer one, the configuration usually read as an uptrend.
The published analyst target is $14.15, 110.6% above it. A target is an aggregate of opinions, not a measurement.
How Achieve Life Sciences Inc (ACHV) is trading
Achieve Life Sciences Inc (ACHV) is up 5.41% at $6.72. A move that large in a single session sits well outside the normal daily range for most stocks.
The session ranged from $6.25 to $6.75 — 7.4% of the share price — and the current price sits at 94% of that range.
It opened at $6.50 against a previous close of $6.38 — an opening gap of +2.0%, which almost always comes from information released outside trading hours.
Volume ran near 1.1M shares, about $7.2M of stock changing hands.
Traded alongside ACHV
Names traded alongside ACHV in the same sector: A (Agilent Technologies Inc), AAPG (Ascentage Pharma Group International), AARD (Aardvark Therapeutics Inc), ABCL (AbCellera Biologics Inc), ABEO (Abeona Therapeutics Inc).
What VAQO's model says about ACHV
Two statistical models run over ACHV inside the browser, reporting momentum, risk and opportunity separately. Full accuracy for both, including when it falls, is published on the model page.
Key facts
- Symbol: ACHV
- Name: Achieve Life Sciences Inc
- Sector: HEALTHCARE
- Industry: BIOTECHNOLOGY
- Exchange: NASDAQ
- Instrument: Stock
ACHV — frequently asked questions
What is the market cap of ACHV?
Achieve Life Sciences Inc has a market capitalisation of roughly $724.8M.
What is the 52-week range for ACHV?
ACHV has traded between $2.62 and $8.64 over the past year, with the current price at 68% of that range.
How much does ACHV stock cost today?
Achieve Life Sciences Inc (ACHV) trades at $6.72, a change of +5.41% in the latest session.
Is ACHV up or down today?
ACHV is up 5.41% in the latest session, at $6.72.
What is the daily trading range for ACHV?
ACHV traded between $6.25 and $6.75 in the latest session, and currently trades at $6.72.
What is the trading volume for ACHV?
ACHV traded roughly 1.1M shares in the latest session.
Which exchange is ACHV listed on?
ACHV is listed on NASDAQ, in the HEALTHCARE sector.
Should I buy ACHV stock?
VAQO gives no buy or sell recommendations and is not an investment adviser. The ACHV figures on this page — price, range, volume and the model's scores — are there to inform your decision, not to stand in for it.
Others in HEALTHCARE
- A — Agilent Technologies Inc
- AAPG — Ascentage Pharma Group International
- AARD — Aardvark Therapeutics Inc
- ABCL — AbCellera Biologics Inc
- ABEO — Abeona Therapeutics Inc
- ABOS — Acumen Pharmaceuticals Inc
Last updated: 2026-11-08